neuropeptidic

English Journal

Fernández-López JA, Remesar X, Foz M, Alemany M.SourceCentre Especial de Recerca en Nutrició i Ciència dels Aliments, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain.
Drugs.Drugs.2002;62(6):915-44.
The high incidence of obesity, its multifactorial nature, the complexity and lack of knowledge of the bodyweight control system, and the scarcity of adequate therapeutics have fuelled anti-obesity drug development during a considerable number of years. Irrespective of the efforts invested by researc
PMID 11929339

[Pharmacologic aspects of the effect of air pollutants on the respiratory system].

Visnovský P, Chmelarová I, Péc M.SourceKatedra farmakologie a toxikologie Farmaceutické fakulty Univerzity Karlovy, Hradec Králové.
Ceská a Slovenská farmacie : casopis Ceské farmaceutické spolecnosti a Slovenské farmaceutické spolecnosti.Ceska Slov Farm.1995 Aug;44(4):201-2.
The principal pharmacologically acting pollutants of the atmosphere in this country are sulfur dioxide and ozone. Sulfur dioxide produces bronchial hyperreactivity, damages the bronchial epithelium and reflexively increases the secretion of phlegm. The explanation of pharmacological mechanisms of it
PMID 7663873

A new series of photoactivatable and iodinatable linear vasopressin antagonists.

Carnazzi E, Aumelas A, Barberis C, Guillon G, Seyer R.SourceUPR 9023 CNRS, Mécanismes Moléculaires des Communications Cellulaires, Montpellier, France.
Journal of medicinal chemistry.J Med Chem.1994 Jun 10;37(12):1841-9.
A series of new linear photoactivatable and iodinatable antagonists of the neuropeptidic hormone vasopressin was designed and synthesized by a combination of PyBOP-mediated Boc/solid-phase peptide synthesis and solution synthesis approaches. These were based on modifications of a previously reported
PMID 8021923